Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

5-aza-2-deoxycytidine With Pegylated Interferon-alfa 2B: A Phase I Study With Molecular Correlates

This study has been terminated.
(low accrual)
National Institutes of Health (NIH)
Information provided by:
Nevada Cancer Institute Identifier:
First received: April 21, 2009
Last updated: July 19, 2011
Last verified: July 2011
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2010
  Primary Completion Date: August 2010 (Final data collection date for primary outcome measure)